These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9293618)

  • 41. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
    Desmoulins PO; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs.
    Mochel JP; Peyrou M; Fink M; Strehlau G; Mohamed R; Giraudel JM; Ploeger B; Danhof M
    J Vet Pharmacol Ther; 2013 Apr; 36(2):174-80. PubMed ID: 22568394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic effects of benazeprilat in the anesthetized dog with acute left ventricular failure.
    Nakazawa M; Sawanobori T; Iwasaki K; Imai S
    Jpn J Pharmacol; 1991 Jul; 56(3):369-75. PubMed ID: 1895581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs.
    Lantis AC; Ames MK; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
    J Vet Pharmacol Ther; 2015 Feb; 38(1):65-73. PubMed ID: 25224804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and pharmacodynamics of trandolapril after repeated administration of 2 mg to young and elderly patients with mild-to-moderate hypertension.
    Arner P; Wade A; Engfeldt P; Mouren M; Stepniewski JP; Sultan E; Bryce T; Lenfant B
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S44-9. PubMed ID: 7527101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous determination of lercanidipine, benazepril and benazeprilat in plasma by LC-MS/MS and its application to a toxicokinetics study.
    Chen K; Zhang J; Liu S; Zhang D; Teng Y; Wei C; Wang B; Liu X; Yuan G; Zhang R; Zhao W; Guo R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 899():1-7. PubMed ID: 22622066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Brunner-Ferber F; Brunner HR; Biollaz J
    Eur J Clin Pharmacol; 2000 Jan; 55(10):749-54. PubMed ID: 10663454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-response of benazepril on biomarkers of the classical and alternative pathways of the renin-angiotensin-aldosterone system in dogs.
    Sotillo S; Ward JL; Guillot E; Domenig O; Yuan L; Smith JS; Gabriel V; Iennarella-Servantez CA; Mochel JP
    Sci Rep; 2023 Feb; 13(1):2684. PubMed ID: 36792677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of the angiotensin converting enzyme inhibitor benazeprilat in plasma and urine by an enzymic method.
    Graf P; Frueh F; Schmid K
    J Chromatogr; 1988 Mar; 425(2):353-61. PubMed ID: 2836452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative determination of benazepril and benazeprilat in human plasma by gas chromatography-mass spectrometry using automated 96-well disk plate solid-phase extraction for sample preparation.
    Pommier F; Boschet F; Gosset G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):199-205. PubMed ID: 12450539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteers.
    Bani M; Colantoni A; Guillaume M; Macchi F; Moroni G; Persiani S
    Br J Clin Pharmacol; 2000 Oct; 50(4):338-49. PubMed ID: 11012557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
    Harder S; Thürmann PA; Ungethüm W
    Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.
    Waeber G; Fasanella d'Amore T; Nussberger J; Waeber B; Brunner HR
    Eur J Clin Pharmacol; 1987; 31(6):643-6. PubMed ID: 3030765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers.
    Hübner R; Högemann AM; Sunzel M; Riddell JG
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S19-25. PubMed ID: 9331000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Simultaneous determination of amlodipine, benazepril and benazeprilat in human plasma by LC-HESI/MS/MS method].
    Pan HL; Lin LS; Ding JF; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2014 Jan; 49(1):95-100. PubMed ID: 24783513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and biochemical efficacy of idrapril calcium, a novel ACE inhibitor, after multiple oral administration in humans.
    Wyld PJ; Grant J; Lippi A; Criscuoli M; Del Re G; Subissi A
    Br J Clin Pharmacol; 1994 Nov; 38(5):421-5. PubMed ID: 7893583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects.
    Louis WJ; Workman BS; Conway EL; Worland P; Rowley K; Drummer O; McNeil JJ; Harris G; Jarrott B
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):505-11. PubMed ID: 1279299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacodynamic evaluation of 4 angiotensin-converting enzyme inhibitors in healthy adult horses.
    Afonso T; Giguère S; Rapoport G; Berghaus LJ; Barton MH; Coleman AE
    J Vet Intern Med; 2013; 27(5):1185-92. PubMed ID: 23952255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel statistical approach for the comparison of analytical methods to measure angiotensin converting enzyme activity, enalaprilat, and benazeprilat.
    Wade JR; Hughes DM; Kelman AW; Howie CA; Meredith PA
    J Pharm Sci; 1993 May; 82(5):471-4. PubMed ID: 8395597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects.
    Witte PU; Irmisch R; Hajdú P; Metzger H
    Eur J Clin Pharmacol; 1984; 27(5):577-81. PubMed ID: 6097458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.